Healthcare

US health insurer Humana witnessed a dramatic sell-off in its stock after presenting mixed quarterly results and significantly revising its...

The independent public trading journey of Nevro has reached its conclusion. Effective April 3, 2025, the company's shares are no...

The financial stability of ModivCare appears increasingly fragile as the company navigates a complex Chapter 11 bankruptcy process. With a...

The publicly traded chapter of Asensus Surgical has concluded following its complete acquisition by the KARL STORZ Group. The company's...

Centene shares have endured a punishing period in the markets, plummeting over 40% year-to-date. However, the healthcare giant's latest quarterly...

The investment community is watching closely as Stereotaxis, a pioneer in robotic medical technology, prepares to release its quarterly earnings....

The shares of Canadian artificial intelligence specialist Healwell AI are attracting significant market attention following a period of transformative corporate...

A recent decision by the European Patent Office has positioned BioNxt Solutions for a potential breakthrough in multiple sclerosis treatment....

UnitedHealth Group, a dominant force in the American health insurance sector, is confronting significant operational pressures from two separate directions....

Clinical-stage biopharmaceutical company NovaBridge Biosciences, formerly known as I-Mab, has released compelling updated Phase 1 data for its bispecific antibody...